[Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]

by Gianluca Furneri, Chiara Marchesi, Laura Santoni
Published 2016-03-01

Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model.

by Gianluca Furneri, Romy Klausnitzer, Laura Haycock, Zenichi Ihara
Published 2019-01-01

Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy

by Gianluca Furneri, Laura Santoni, Chiara Ricella, Luca Prosperini
Published 2019-06-01

Venous thrombo-embolism (VTE) prevention of patients undergoing total hip and knee replacement: budget impact analysis of apixaban in Italy

by Lorenzo Giovanni Mantovani, Giovanni Di Minno, Gianluca Furneri
Published 2013-09-01

Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy

by Antonio Maria Fea, Francesco Cattel, Stefano Gandolfi, Giorgio Buseghin, Gianluca Furneri, Ciro Costagliola
Published 2021-08-01

Analisi costo-utilità di dupilumab per il trattamento della dermatite atopica grave negli adulti in Italia

by Antonio Costanzo, Gianluca Furneri, Rossella Bitonti, Maria Paola Pedone, Francesca Fanelli, Roberta Di Turi
Published 2020-08-01

Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective

by Lorenzo Giovanni Mantovani, Gianluca Furneri, Rossella Bitonti, Paolo Cortesi, Elisa Puma, Laura Santoni, Luca Prosperini
Published 2019-07-01

[Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]

by Gianluca Furneri, Laura Santoni, Chiara Marchesi, Sergio Iannazzo, Paolo Angelo Cortesi, Achille Patrizio Caputi, Lorenzo Giovanni Mantovani
Published 2016-06-01

Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis

by Giorgio Walter Canonica, Francesco Blasi, Nunzio Crimi, Pierluigi Paggiaro, Alberto Papi, Francesca Fanelli, Annalisa Stassaldi, Gianluca Furneri
Published 2021-05-01

Cetuximab in first line treatment of metastatic colorectal cancer

by Carlo Barone, Andrea Belisari, Fortunato Ciardiello, Lorenzo Mantovani, Lucia D’Angiolella, Gianluca Furneri, Nicola Normanno, Patrizio Piacentini, Carmine Pinto
Published 2012-07-01

Epidemiologia, prevenzione e trattamento delle malattie cardiovascolari: evidenze dal database della medicina generale

by Giampiero Mazzaglia, Alessandro Filippi, Lorenzo G. Mantovani, Gianluca Furneri, Carlo Niccolai, Jacopo Cricelli, Achille P. Caputi, Ovidio Brignoli, Claudio Cricelli
Published 2011-05-01

Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases.

by Luciana Scalone, Giancarlo Cesana, Gianluca Furneri, Roberta Ciampichini, Paolo Beck-Peccoz, Virginio Chiodini, Silvia Mangioni, Emanuela Orsi, Carla Fornari, Lorenzo Giovanni Mantovani
Published 2014-01-01

[Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]

by Lorenzo Giovanni Mantovani, Gianluca Furneri, Paolo Angelo Cortesi, Maria Pia Amato, Achille Patrizio Caputi, Patrizio Piacentini, Alessandra Solari, Carlo Pozzilli, Giancarlo Comi
Published 2017-12-01